Literature DB >> 20101416

An exploration of the influences on clinical decision making and the culture of blood transfusion practise in cancer-related anaemia using an ethnographic methodology.

Liz Bishop1, Sara Faithfull, Helen Allan.   

Abstract

PURPOSE: This study seeks to explore the cultural practises, which shape the culture of transfusion, and to identify the key elements, which influence clinical decision making in blood transfusion in haemato-oncology and lung cancer patients.
METHODS: The assessment and decision making processes for blood transfusion were explored using fieldwork observation, six patient and nine clinician interviews based on ethnographic methodology. Data were analysed using thematic analysis.
RESULTS: First, the findings suggested that despite anaemia and transfusion being ubiquitous in this cancer setting, it sits low in the hierarchy of clinical concerns (The unimportance of anaemia). Second, there is a great deal of uncertainty surrounding the diagnosis and management of this clinical problem; but this uncertainty was acknowledged by both patients and clinicians (Acknowledging uncertainty). Third, clinicians and to some extent patients, are socialised into the practise of the sub-discipline (Socialisation in practise). Fourth, the haemoglobin level was used as a distinct fragment of information on which to assess for the presence of anaemia and base the decision to treat with blood transfusion (Disaggregation of the body).
CONCLUSION: The management of anaemia is not a priority in this setting; however, by understanding the complexity of factors for variation in practise in the clinical context, new models for learning transfusion skills can be developed. Furthermore, different collaborative groups could be organised to develop optimal transfusion practises, for example to include nurse-prescribing of blood components or by developing patient-centred decision making systems.

Entities:  

Mesh:

Year:  2010        PMID: 20101416     DOI: 10.1007/s00520-009-0801-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

Review 1.  Anemia and fatigue in cancer patients.

Authors:  J Glaspy
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 2.  Risks of blood transfusion.

Authors:  Lawrence T Goodnough
Journal:  Crit Care Med       Date:  2003-12       Impact factor: 7.598

Review 3.  Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications.

Authors:  C Madjdpour; D R Spahn
Journal:  Br J Anaesth       Date:  2004-10-14       Impact factor: 9.166

4.  Person-centred care.

Authors:  Kim Manley; Brendan McCormack
Journal:  Nurs Manag (Harrow)       Date:  2008-12

5.  Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

Authors:  J J Caro; M Salas; A Ward; G Goss
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

6.  Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.

Authors:  L M Williamson; S Lowe; E M Love; H Cohen; K Soldan; D B McClelland; P Skacel; J A Barbara
Journal:  BMJ       Date:  1999-07-03

7.  How physicians use clinical information in diagnosing pulmonary embolism: an application of conjoint analysis.

Authors:  R S Wigton; V L Hoellerich; K D Patil
Journal:  Med Decis Making       Date:  1986 Jan-Mar       Impact factor: 2.583

8.  Influence of knowledge and attitudes on the quality of physicians' transfusion practice.

Authors:  S R Salem-Schatz; J Avorn; S B Soumerai
Journal:  Med Care       Date:  1993-10       Impact factor: 2.983

Review 9.  Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.

Authors:  G D Demetri
Journal:  Br J Cancer       Date:  2001-04       Impact factor: 7.640

10.  Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy.

Authors:  P J Barrett-Lee; N P Bailey; M E O'Brien; E Wager
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.